{"url_path":"/sec/glsi/10-k/2026/item-13","section_key":"item-13","section_title":"Item 13 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","accession_number":"0001493152-26-026651","cik":"0001799788","ticker":"GLSI","issuer_name":"Greenwich LifeSciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","primary_entity_key":"0001799788","primary_entity_name":"Greenwich LifeSciences, Inc."},"word_count":813,"has_tables":true,"body_markdown":"**ITEM\n13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE**\n\n \n\nThe\nfollowing includes a summary of transactions since January 1, 2023 to which we have been a party, including transactions in which the\namount involved in the transaction exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two\ncompleted fiscal years, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5%\nof our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material\ninterest, other than equity and other compensation, termination, change in control and other arrangements, which are described elsewhere\nin this Annual Report on Form 10-K. We are not otherwise a party to a current related party transaction, and no transaction is currently\nproposed, in which the amount of the transaction exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end\nfor the last two completed fiscal years and in which a related person had or will have a direct or indirect material interest.\n\n \n\n65\n\n[Table of Contents](#toc_001)\n\n \n\n**Related\nPerson Transaction Policy**\n\n \n\nWe\nadopted a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval\nor ratification of related person transactions. For purposes of our policy only, a related person transaction is a transaction, arrangement\nor relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or\nwill be participants in which the amount involved exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end.\nTransactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related\nperson is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of\ntheir immediate family members and any entity owned or controlled by such persons.\n\n \n\nUnder\nthe policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person\ntransaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to\nconsummation, our management must present information regarding the related person transaction to our audit committee, or, if audit committee\napproval would be inappropriate, to another independent body of our board of directors, for review, consideration and approval or ratification.\nThe presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related\npersons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to\nor from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information\nthat we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable\nus to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our\ncode of business conduct and ethics, our employees and directors have an affirmative responsibility to disclose any transaction or relationship\nthat reasonably could be expected to give rise to a conflict of interest. In considering related person transactions, our audit committee,\nor other independent body of our board of directors, will take into account the relevant available facts and circumstances including,\nbut not limited to:\n\n \n\n \n●\nthe\nrisks, costs and benefits to us;\n\n \n \n \n\n \n●\nthe\nimpact on a director’s independence in the event that the related person is a director, immediate family member of a director\nor an entity with which a director is affiliated;\n\n \n \n \n\n \n●\nthe\navailability of other sources for comparable services or products; and\n\n \n \n \n\n \n●\nthe\nterms available to or from, as the case may be, unrelated third parties or to or from employees generally.\n\n \n\nThe\npolicy requires that, in determining whether to approve, ratify or reject a related person transaction, our audit committee, or other\nindependent body of our board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not\ninconsistent with, our best interests and those of our stockholders, as our audit committee, or other independent body of our board of\ndirectors, determines in the good faith exercise of its discretion.\n\n \n\n**Director\nIndependence**\n\n \n\nOur\nboard of directors undertook a review of the independence of our directors and considered whether any director has a relationship with\nus that could compromise that director’s ability to exercise independent judgment in carrying out that director’s responsibilities.\nOur board of directors has affirmatively determined that David McWilliams, Eric Rothe and Kenneth Hallock are each an “independent\ndirector,” as defined under the Nasdaq rules."}